How much funding has CG Oncology raised?

CG Oncology has raised $317.6M in total funding, most recently a series f round.

Who are CG Oncology's investors?

CG Oncology's investors include TCG Crossover, ORI Capital, Longitude Capital, WI Harper Group, Ally Bridge Group, RA Capital Management.

Where is CG Oncology headquartered?

CG Oncology is headquartered in Irvine, California, United States.

What industry is CG Oncology in?

CG Oncology operates in Biotech, Healthcare.

How many employees does CG Oncology have?

CG Oncology has 51-200 employees.

CG Oncology

IPO

Focused on the Future of Bladder Cancer

Public · Irvine, United States · $317.6M raised

Biotech

Healthcare

Headquarters: Irvine, California
Employees: 51–200
Business Model: B2B
Website: cgoncology.com

Total Funding: $317.6M
Last Round: $105.0M Series FAug 2023
Rounds: 6
Type: Public

About

CG Oncology is a late-stage clinical biopharmaceutical company developing and commercializing bladder-sparing immunotherapies, with a lead program targeting non-muscle-invasive bladder cancer.

Summary

CG Oncology is a Biotech company based in Irvine, United States. It has raised $317.6M in total across 6 rounds, most recently a $105.0M Series F round in Aug 2023. Investors include TCG Crossover, ORI Capital and Longitude Capital.

X (Twitter)